Vincent H. Bono

586 total citations
21 papers, 437 citations indexed

About

Vincent H. Bono is a scholar working on Molecular Biology, Oncology and Organic Chemistry. According to data from OpenAlex, Vincent H. Bono has authored 21 papers receiving a total of 437 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 7 papers in Oncology and 3 papers in Organic Chemistry. Recurrent topics in Vincent H. Bono's work include Biochemical and Molecular Research (4 papers), Amino Acid Enzymes and Metabolism (2 papers) and Cancer, Hypoxia, and Metabolism (2 papers). Vincent H. Bono is often cited by papers focused on Biochemical and Molecular Research (4 papers), Amino Acid Enzymes and Metabolism (2 papers) and Cancer, Hypoxia, and Metabolism (2 papers). Vincent H. Bono collaborates with scholars based in United States, Malaysia and Austria. Vincent H. Bono's co-authors include Emil Frei, Paul P. Carbone, Clyde O. Brindley, Robert L. Dion, Lafayette Noda, J. A. Fernandez‐Pol, Lawrence F. Kress, George S. Johnson, Kurt W. Kohn and Paul V. Woolley and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Journal of Clinical Investigation.

In The Last Decade

Vincent H. Bono

18 papers receiving 376 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Vincent H. Bono United States	12	207	105	61	46	44	21	437
G Franchi Italy	11	131 0.6×	177 1.7×	46 0.8×	19 0.4×	28 0.6×	32	456
Carol Hartke United States	11	295 1.4×	237 2.3×	86 1.4×	57 1.2×	71 1.6×	13	638
J. Thomson United Kingdom	11	268 1.3×	97 0.9×	30 0.5×	21 0.5×	15 0.3×	15	479
Nahed K. Ahmed United States	13	272 1.3×	87 0.8×	29 0.5×	67 1.5×	60 1.4×	30	533
Masaki Gouda Japan	9	235 1.1×	85 0.8×	49 0.8×	32 0.7×	37 0.8×	11	385
Ashok R. Bapat United States	13	344 1.7×	167 1.6×	135 2.2×	69 1.5×	35 0.8×	20	813
H. Rogg Switzerland	18	905 4.4×	54 0.5×	38 0.6×	39 0.8×	23 0.5×	30	1.3k
Thomas T. Tibbitts United States	11	308 1.5×	54 0.5×	34 0.6×	49 1.1×	22 0.5×	15	472
Kam H. Leung United States	14	300 1.4×	153 1.5×	44 0.7×	20 0.4×	35 0.8×	22	814
Alex Goldstein United States	13	262 1.3×	82 0.8×	58 1.0×	18 0.4×	14 0.3×	19	517

Countries citing papers authored by Vincent H. Bono

Since Specialization

Citations

This map shows the geographic impact of Vincent H. Bono's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Vincent H. Bono with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Vincent H. Bono more than expected).

Fields of papers citing papers by Vincent H. Bono

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Vincent H. Bono. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Vincent H. Bono. The network helps show where Vincent H. Bono may publish in the future.

Co-authorship network of co-authors of Vincent H. Bono

This figure shows the co-authorship network connecting the top 25 collaborators of Vincent H. Bono. A scholar is included among the top collaborators of Vincent H. Bono based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Vincent H. Bono. Vincent H. Bono is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Muggia, Franco M., Vincent H. Bono, & V T DeVita. (2015). New Anticancer Drugs. Antibiotics and chemotherapy/Antibiotica et chemotherapia. 23. 42–49.

Sieber, S. M., Mary K. Wolpert, Richard H. Adamson, et al.. (2015). Experimental Studies with Maytansine - A New Antitumor Agent. Proceedings of the International Symposium on Comparative Leukemia Research. 495–500.

Catane, Raphael, Marcel Rozencweig, Vincent H. Bono, et al.. (1980). Analysis and interpretation of response rates for anticancer drugs.. PubMed. 63(11-12). 1713–20. 17 indexed citations

Bono, Vincent H.. (1980). The effect of drug mechanisms of action and pharmacology on the interaction. International Journal of Radiation Oncology*Biology*Physics. 6(7). 961–962. 2 indexed citations

Canellakis, Z.N., et al.. (1979). Surface alterations of P388 leukemia cells by 2-deoxy-d-glucose. Biochemical Pharmacology. 28(12). 1953–1957. 3 indexed citations

Cooney, David A., Harry A. Milman, Ritchard G. Cable, et al.. (1978). Maleimide—Biochemical, pharmacologic and toxicologic studies. Biochemical Pharmacology. 27(2). 151–166. 6 indexed citations

Bhuyan, B. K., et al.. (1978). Effects of chartreusin on cell survival and cell cycle progression.. PubMed. 38(9). 2734–9. 4 indexed citations

Bhuyan, Bijoy K., et al.. (1977). Partial synchronization of L1210 cells by 5-fluorouracil and its use in drug combinations.. PubMed. 37(9). 3204–8. 12 indexed citations

Woolley, Paul V., Robert L. Dion, Kurt W. Kohn, & Vincent H. Bono. (1976). Binding of 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea to L1210 cell nuclear proteins.. VocBench (University of Rome Tor Vergata). 36(4). 1470–4. 20 indexed citations

10.

Canellakis, E.S., et al.. (1976). Diacridines: Bifunctional intercalators III. Definition of the general site of action. Biochimica et Biophysica Acta (BBA) - Nucleic Acids and Protein Synthesis. 418(3). 300–314. 22 indexed citations

11.

Wolpert-DeFilippes, Mary K., Vincent H. Bono, Robert L. Dion, & David G. Johns. (1975). Initial studies on maytansine-induced metaphase arrest in 11210 mürine leukemia cells. Biochemical Pharmacology. 24(18). 1735–1738. 30 indexed citations

12.

Bono, Vincent H., et al.. (1975). L1210 murine leukemia cells.. The Mouseion at the JAXlibrary (Jackson Laboratory). 1735. 1 indexed citations

13.

Woolley, Paul V., Robert L. Dion, & Vincent H. Bono. (1974). Effects of tryptophan deprivation on L1210 cells in culture.. PubMed. 34(5). 1010–4. 22 indexed citations

14.

Colvin, Michael & Vincent H. Bono. (1970). The enzymatic reduction of hydroxyurea to urea by mouse liver.. PubMed. 30(5). 1516–9. 20 indexed citations

15.

Kohn, Kurt W., Vincent H. Bono, & Herbert E. Kann. (1968). Anthramycin, a new type of DNA-inhibiting antibiotic: Reaction with DNA and effect on nucleic acid synthesis in mouse leukemia cells. Biochimica et Biophysica Acta (BBA) - Nucleic Acids and Protein Synthesis. 155(1). 121–129. 30 indexed citations

16.

Kress, Lawrence F., Vincent H. Bono, & Lafayette Noda. (1966). The Sulfhydryl Groups of Rabbit Muscle Adenosine Triphosphate-Adenosine Monophosphate Phosphotransferase. Journal of Biological Chemistry. 241(10). 2293–2300. 55 indexed citations

17.

Bono, Vincent H., C. C. Cheng, Emil Frei, & Margaret G. Kelly. (1964). MEHTYL-5-FLUOROOROTATE: SYNTHESIS AND COMPARISON WITH 5-FLUOROOROTIC ACID WITH RESPECT TO BIOLOGICAL ACTIVITY AND CELL ENTRY.. PubMed. 24. 513–7. 6 indexed citations

18.

Bono, Vincent H., S M Weissman, & Emil Frei. (1964). The Effect of 6-Azauridine Administration on De Novo Pyrimidine Production in Chronic Myelogenous Leukemia*. Journal of Clinical Investigation. 43(7). 1486–1494. 14 indexed citations

19.

Carbone, Paul P., Vincent H. Bono, Emil Frei, & Clyde O. Brindley. (1963). Clinical Studies with Vincristine. Blood. 21(5). 640–647. 117 indexed citations

20.

Weissman, S M, Vincent H. Bono, & M. Lewis. (1963). Metabolic Inertness of Orotidine in Man and the Rat. Experimental Biology and Medicine. 114(3). 682–685. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact